Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial to Test the Effect of Rivaroxaban or Apixaban on Menstrual Blood Loss in Women

NCT02829957 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT02829957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02829957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial to Test the Effect of Rivaroxaban or Apixaban on Menstrual Blood Loss in Women
Lead sponsor
Indiana University
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2016
Completion date
February 13, 2020
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

menstruation, venous thromboembolism